•i-Lumen Scientific earns FDA IDE clearance for dry AMD trial•TEPEZZA on-body injector demonstrates positive phase 3 performance for TED•Dry eye may indicate early signs of autoimmune disease•FDA issues nationwide voluntary recall for over 3M eye drop bottles•Sydnexis's low-dose atropine shows strong phase 3 efficacy for pediatric myopia•i-Lumen Scientific earns FDA IDE clearance for dry AMD trial•TEPEZZA on-body injector demonstrates positive phase 3 performance for TED•Dry eye may indicate early signs of autoimmune disease•FDA issues nationwide voluntary recall for over 3M eye drop bottles•Sydnexis's low-dose atropine shows strong phase 3 efficacy for pediatric myopia
HEADLINES
FEATURED
Latest next-gen IOL features the new Opti-Blance Technology design to increase DOF without sacrificing distance vision quality
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
